Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: Evidence from a human metabolomic study and in vitro experiments
BMC Gastroenterology Jul 16, 2018
Liu Z, et al. - For this investigation, 32 cirrhotic patients and 27 healthy volunteers were recruited to identify the specific bile acid and investigate its possible mechanisms in promoting liver cirrhosis, as well as to find a potential therapeutic target for liver cirrhosis. Researchers collected age, gender, Child-Pugh classification and serum of patients and volunteers. They used the Spearman rank correlation analysis to evaluate the association between concentrations of bile acids and Child-Pugh classification. Increased taurocholic acid (TCA) concentration in cirrhosis was mainly due to increased bile acid biosynthesis. They reported that TCA was an active promoter of the progression of liver cirrhosis. Findings suggested that TCA promoting liver cirrhosis was likely through activating hepatic stellate cells by means of upregulating Toll-like receptor 4 (TLR4) expression. For the prevention and treatment of liver cirrhosis, TCA was a potential therapeutic target.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries